These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37123789)

  • 1. A Systematic Review Exploring the Range of Renal Complications of Human Immunodeficiency Virus.
    Yussuf FM; Barbarawi A; Nor MA; Ali AI; Sheikh IM; Ogedegbe OJ; Tabowei G; Jimoh A; Ozokolie GE; Igbinomwanhia O
    Cureus; 2023 Mar; 15(3):e36755. PubMed ID: 37123789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Patient Experience of Hemophilia and Human Immunodeficiency Virus: A Systematic Review of Qualitative Evidence.
    Omura K; Tsuchiya S
    JBI Libr Syst Rev; 2012; 10(58):4659-4668. PubMed ID: 27820530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillary glomerulonephritis in a human immunodeficiency virus-positive, hepatitis C-negative Indian patient: Expanding the profile of renal involvement in human immunodeficiency virus infection.
    Matthai SM; Valson AT; Duhli N; Rupali P; Pulimood AB; Varughese S
    Indian J Pathol Microbiol; 2018; 61(4):610-613. PubMed ID: 30303165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of HIV-associated immune complex kidney disease.
    Booth JW; Hamzah L; Jose S; Horsfield C; O'Donnell P; McAdoo S; Kumar EA; Turner-Stokes T; Khatib N; Das P; Naftalin C; Mackie N; Kingdon E; Williams D; Hendry BM; Sabin C; Jones R; Levy J; Hilton R; Connolly J; Post FA;
    Nephrol Dial Transplant; 2016 Dec; 31(12):2099-2107. PubMed ID: 26786550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
    Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Antiretroviral Therapy on Kidney Disease in HIV Infected Individuals - A Qualitative Systematic Review.
    Adnani H; Agrawal N; Khatri A; Vialet J; Zhang M; Cervia J
    J Int Assoc Provid AIDS Care; 2022; 21():23259582221089194. PubMed ID: 35369795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Sangani P; Rutherford G; Wilkinson D
    Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated nephropathy: case study and review of the literature.
    Ross MJ; Klotman PE; Winston JA
    AIDS Patient Care STDS; 2000 Dec; 14(12):637-45. PubMed ID: 11119430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease in human immunodeficiency virus infection.
    Fabian J; Katz I; Gerntholtz T; Goetsch S; Naicker S
    Panminerva Med; 2007 Jun; 49(2):51-66. PubMed ID: 17625482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-related nephropathy: a South African perspective.
    Gerntholtz TE; Goetsch SJ; Katz I
    Kidney Int; 2006 May; 69(10):1885-91. PubMed ID: 16625149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Wilkinson D; Rutherford G
    Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risky sexual practice and associated factors among people living with HIV/AIDS receiving antiretroviral therapy in Ethiopia: Systematic review and meta-analysis.
    Hareru HE; Kaso AW; Ashuro Z; Mareg M
    PLoS One; 2022; 17(4):e0266884. PubMed ID: 35421163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to HIV prevention interventions for reducing risky sexual behavior among youth worldwide: a systematic review.
    Mbengo F; Adama E; Towell-Barnard A; Bhana A; Zgambo M
    BMC Infect Dis; 2022 Aug; 22(1):679. PubMed ID: 35941562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy and treatment options for HIV-associated nephropathy.
    Menez S; Hanouneh M; McMahon BA; Fine DM; Atta MG
    Expert Opin Pharmacother; 2018 Jan; 19(1):39-48. PubMed ID: 29224373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 and kidney cells: better understanding of viral interaction.
    Mikulak J; Singhal PC
    Nephron Exp Nephrol; 2010; 115(2):e15-21. PubMed ID: 20407278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review protocol of the effectiveness of HIV prevention interventions for reducing risky sexual behaviour among youth globally.
    Mbengo F; Zgambo M; Afrifa-Yamoah E; Kalembo FW; Honda T; Shimpuku Y; Chen S
    BMJ Open; 2022 May; 12(5):e056929. PubMed ID: 35568486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease in patients infected with human immunodeficiency virus: a systematic review.
    Pires LB; Rocha R; Vargas D; Daltro C; Cotrim HP
    Rev Assoc Med Bras (1992); 2020; 66(1):81-86. PubMed ID: 32130386
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.